Healthcare Analytics: Examining the Diagnosis–treatment Cycle

Abstract Research has demonstrated that the patients’ diagnosis-treatment cycles often significantly deviate from the standardized clinical pathways. Analyzing these deviations might result in the further enhancement of the quality of care, the promotion of patient safety, an increase in patient satisfaction and an optimization of the use of resources. Understanding pathway behavior and deviations becomes possible because of an increased availability of reliable data, which originates from the hospitals information systems. In this paper we propose a clinical pathway analysis method for extracting valuable medical and organizational information on past diagnosis-treatment cycles that can be attributed to a specific clinical pathway. The method is applied on the clinical pathway processes in a Gynecologic Oncology Department.

[1]  Jeffrey Bell,et al.  Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. , 2006, Gynecologic oncology.

[2]  S. Rodenhuis,et al.  Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[4]  Wil M. P. van der Aalst,et al.  Process diagnostics using trace alignment: Opportunities, issues, and challenges , 2012, Inf. Syst..

[5]  Peep F M Stalmeier,et al.  Adherence and Decision Aids , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[6]  Karen Beckman Pace,et al.  Barriers to successful implementation of a clinical pathway for CHF. , 2002, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[7]  Bart Baesens,et al.  Advanced Care-Flow Mining and Analysis , 2011, Business Process Management Workshops.

[8]  W W Stead,et al.  The IAIMS--an essential infrastructure for increasing the competitiveness of health care practices. , 1997, Journal of the American Medical Informatics Association : JAMIA.

[9]  Haider Mahdi,et al.  Clinical trials and progress with paclitaxel in ovarian cancer , 2010, International journal of women's health.

[10]  S. Arikian,et al.  Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Gerbaulet,et al.  The GEC ESTRO handbook of brachytherapy , 2002 .

[12]  M. Schnabel,et al.  Improving pathway compliance and clinician performance by using information technology. , 2007, International journal of medical informatics.

[13]  Kim M. Unertl,et al.  Research Paper: Describing and Modeling Workflow and Information Flow in Chronic Disease Care , 2009, J. Am. Medical Informatics Assoc..

[14]  Andrew G. Lee,et al.  A Practice Pathway for the Initial Diagnostic Evaluation of Isolated Sixth Cranial Nerve Palsies , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  Kai Zheng,et al.  Quantifying the impact of health IT implementations on clinical workflow: a new methodological perspective , 2010, J. Am. Medical Informatics Assoc..

[16]  M. Ball An Overview of Total Medical Information Systems , 1971, Methods of Information in Medicine.

[17]  Heikki Korvenranta,et al.  Internet based patient pathway as an educational tool for breast cancer patients , 2012, Int. J. Medical Informatics.

[18]  Zhibin Jiang,et al.  An ontology-based hierarchical semantic modeling approach to clinical pathway workflows , 2009, Comput. Biol. Medicine.

[19]  Kim M. Unertl,et al.  Health information exchange technology on the front lines of healthcare: workflow factors and patterns of use , 2011, J. Am. Medical Informatics Assoc..

[20]  Kris Vanhaecht,et al.  Care Pathways are defined as complex interventions , 2010 .

[21]  Jeffrey J H Low,et al.  Epithelial ovarian cancer , 2018, An Atlas of Gynecologic Oncology.

[22]  Thomas Rotter,et al.  Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. , 2010, The Cochrane database of systematic reviews.

[23]  Wil M. P. van der Aalst,et al.  Conformance checking of processes based on monitoring real behavior , 2008, Inf. Syst..

[24]  Manfred Reichert,et al.  IT support for healthcare processes - premises, challenges, perspectives , 2007, Data Knowl. Eng..